We observed increased ADM expression in CD4+ T cells (GSE14924, p <0.001, Figure 5A) and in CD8+ T lymphocytes (GSE117090, p <0.001, Figure 5B) from AML patients. Here, ADM is linked to acute myeloid leukemia.